Skip to content

Comparison of Soy-milk and Cow Milk Consumption on Inflammatory Factors, Cardiovascular Factors ,Renal Factors, Fibrinolytic Indice and Oxidative Stress Among Type-2 Diabetic Patients With Nephropathy Stage 1 and 2

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01419912
Enrollment
Unknown
Registered
2011-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2011-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation, Oxidative Stress, Fibrinolytic Markers, Blood Pressure and Cardiorenal Risk Factors

Brief summary

Soymilk components such as isoflavones, essential fatty acids, phytoesterols, good fats, inositols might have beneficial effects on controlling complication among diabetic nephropathy patients(DN).Most studies in this regard have been examined the effect of soy consumption on cardiorenal risk factors among patients with DN and there are few data about relationship of soy milk consumption and health effect in patients with DN . Therefore, we evaluated the effects of soy milk compared to cow's milk on blood pressure, inflammation, oxidative stress and fibrinolytic markers and cardiorenal risk factors among these patients. This was a cross-over randomized clinical trial which was conducted in Isfahan among diabetic nephropathy patients. Patients were randomly assigned to consume a diet containing cow's milk or a diet in which only one glass of soy milk was substituted; each one for 4 weeks.

Interventions

DIETARY_SUPPLEMENTsoy milk
DIETARY_SUPPLEMENTcow's milk

Sponsors

Isfahan University of Medical Sciences
Lead SponsorOTHER

Study design

Intervention model
CROSSOVER

Eligibility

Sex/Gender
ALL
Age
28 Years to 81 Years

Inclusion criteria

* adults with (\>18y old) diagnosis of type 2 diabetics nephropathy (diabetics subjects that had proteinuria more than 300 mg/day and had GFR more than 90 mL/min )

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frame
soy milk

Secondary

MeasureTime frame
creatinin
total cholesterol
insulin
systolic blood pressure
diastolic blood pressure
Malondialdehyde
fibrinogen
Urine creatinine
urine protein
HbA1c
TNF-α
IL6
FBS
TG
hs-CRP
d-dimer
HDL
LDL
BUN

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026